Trademark: 90610956
Word
JANUX
Status Date
Tuesday, August 20, 2024
Filing Date
Monday, March 29, 2021
Published for Opposition
Tuesday, July 12, 2022
5 Pharmaceutical products for the treatment of cancer; pharmaceutical products in the field of oncology and immunotherapy
42 Pharmaceutical research and development; drug discovery services; biomedical research services; laboratory research services relating to pharmaceuticals, namely, research in the field of oncology and immunotherapy
Nov 20, 2021
Non-Final Action Written
Apr 1, 2021
New Application Entered
Jul 6, 2021
New Application Office Supplied Data Entered
Nov 5, 2021
Assigned To Examiner
May 5, 2022
Teas Response To Office Action Received
Nov 20, 2021
Non-Final Action E-Mailed
Nov 20, 2021
Notification Of Non-Final Action E-Mailed
Jun 22, 2022
Notification Of Notice Of Publication E-Mailed
May 5, 2022
Correspondence Received In Law Office
May 6, 2022
Teas/Email Correspondence Entered
Jun 9, 2022
Approved For Pub - Principal Register
Jul 12, 2022
Published For Opposition
Jul 12, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 6, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 21, 2023
Sou Teas Extension Received
Feb 21, 2023
Sou Extension 1 Granted
Feb 21, 2023
Sou Extension 1 Filed
Feb 23, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 15, 2023
Sou Teas Extension Received
Aug 17, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 9, 2024
Sou Extension 3 Granted
Aug 15, 2023
Sou Extension 2 Filed
Aug 15, 2023
Sou Extension 2 Granted
Feb 9, 2024
Sou Extension 3 Filed
Feb 9, 2024
Sou Teas Extension Received
Aug 20, 2024
Sou Teas Extension Received
Aug 20, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 20, 2024
Sou Extension 4 Granted
Aug 20, 2024
Sou Extension 4 Filed
Feb 10, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
